Eli Lilly and Company
Wei Zhou, MD, Ph.D., is currently Executive Director and head for Oncology, Pharmacoepidemiology, Center for Observational and Real-world Evidence (CORE) at Merck Research Laboratories. Before that, he was the Executive Director at CORE Product Line, Regional Director and Head of Epidemiology Asia Pacific Unit at Merck, Director of Molecular Epidemiology at Pfizer Oncology, and Senior Epidemiologist at Merck. Wei was a Research Fellow/Research Associate/ Research Scientist at Harvard School of Public Health between June 1999 and December, 2007, where he had contributed to a number of projects on gene-environment interactions in the development and prognosis of different chronic diseases including cancers. Wei is a Fellow of the International Society of Pharmacoepidemiology (ISPE), VP of Finance Elect, and co-chair of the ISPE Real World Evidence Task Force.
Wei received his MD from West China University of Medical Sciences in 1994 and Ph.D of Environmental Health from Shanghai Medical University in 1998. He was the recipient of the John E. Fogarty International Training and Research Program. He has published more than 80 peer-reviewed manuscripts and book chapters, and served as a reviewer for various international journals. Wei has given numerous presentations and served as chair/co-chair at different international conferences and symposiums.